InvestorsHub Logo

SF Anony

03/01/21 6:48 PM

#149424 RE: justdafactss #149415

I've noticed that you've repeated this assertion that the data hasn't been unblinded many times. I feel as though that assertion has been refuted each time, but I may be misremembering, so I'll try to refute it here.

Data doesn't have to be revealed to the public to be "unblinded". It has to be revealed to the sponsor company conducting the trial. That always has and always will be the definition of unblinding.

That's obviated by the fact that the press release statement you call a lie hasn't been questioned by either the FDA or SEC, despite being there for all the world to see. Occam's Razor says that the simplest explanation is often the correct one.

The simplest explanation for why no authority has called the truthfulness of CytoDyn's unblinding into question? They've unblinded the data.

Dieselpro

03/01/21 8:24 PM

#149439 RE: justdafactss #149415

The data is not hidden. The data is at the FDA. And now that the FDA has the data they are choosing to continue OLE for CD12. This can only mean one thing, it's their intention to approve Leronlimab. That's the only logical reason to allow OLE, and eIND to continue.